Bio Essence Corporation
BIOE
$0.23
$0.0188.49%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -1.74M | -1.40M | -1.56M | -680.10K | -659.10K |
| Total Depreciation and Amortization | 800.00 | 1.20K | -29.40K | -13.20K | 2.70K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.48M | 1.20M | 1.25M | 81.40K | -17.10K |
| Change in Net Operating Assets | 1.03M | 818.80K | 341.60K | -93.50K | -292.30K |
| Cash from Operations | 769.40K | 623.90K | -3.30K | -705.20K | -965.50K |
| Capital Expenditure | -- | -- | 0.00 | -3.60K | -3.60K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -100.00 | -100.00 | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -100.00 | -100.00 | -87.90K | -91.50K | -91.50K |
| Total Debt Issued | 155.30K | 0.00 | 331.30K | 849.90K | 1.15M |
| Total Debt Repaid | -924.70K | -613.10K | -123.30K | 42.90K | -10.70K |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | -9.30K | -86.90K | -86.90K | -86.90K |
| Cash from Financing | -769.40K | -622.50K | 121.00K | 805.80K | 1.06M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -200.00 | 1.20K | 29.90K | 9.10K | 0.00 |